Advertisement
Case report| Volume 3, ISSUE 2, P105-108, 1999

Download started.

Ok

Typhoid fever and HIV infection: A rare disease association in industrialized countries

Open ArchiveDOI:https://doi.org/10.1016/S1201-9712(99)90018-8
Typhoid fever and HIV infection: A rare disease association in industrialized countries
Previous ArticleImproved prognosis of Pseudomonas aeruginosca bacteremia in 127 consecutive neutropenic patients with hematologic malignancies
Next ArticleEmerging fungal pathogens, drug resistance and the role of lipid formulations of amphotericin b in the treatment of fungal infections in cancer patients: A review
      This paper is only available as a PDF. To read, Please Download here.

      References

        • Stroffolini T.
        • Manzillo G.
        • De Sena R.
        • et al.
        Typhoid fever in the Neapolitan area: a case-control study.
        Eur J Epidemiol. 1992; 8: 539-542
        • Cristiano P.
        • Imparato L.
        • Carpinelli C.
        • et al.
        Pefloxacin versus chloramphenicol in the therapy of typhoid fever.
        Infection. 1995; 23: 103-106
        • Bhutta Z.A.
        • Naqvi S.H.
        • Razzaq R.A.
        • et al.
        Multidrug-resistant typhoid in children: presentation and clinical features.
        Rev Infect Dis. 1991; 13: 832-836
        • Zenilman J.M.
        Typhoid fever.
        JAMA. 1997; 278: 847-850
        • Atkins B.L.
        • Gottlieb T.
        Emerging drug resistance and vaccination for typhoid fever.
        JAMA. 1998; 279: 579
        • Mermin J.H.
        • Townes J.M.
        • Gerber M.
        • Dolan N.
        • Mintz E.D.
        • Tauxe R.V.
        Typhoid fever in the United States, 1985–1994.
        Arch Intern Med. 1998; 158: 633-638
        • Ruanguan W.
        • Kunming Y.
        • Qiong S.
        Antibiotic therapy for typhoid fever.
        Chemotherapy. 1994; 40: 61-64
        • Lee L.A.
        • Puhr N.D.
        • Maloney E.K.
        • Bean N.H.
        • Tauxe R.V.
        Increase in antimicrobial-resistant Salmonella infections in the United States, 1989–1990.
        J Infect Dis. 1994; 170: 128-134
        • Rowe B.
        • Ward L.R.
        • Threfall E.J.
        Ciprofloxacin-resistant Salmonella typhi in the UK.
        Lancet. 1995; 346: 1302
        • Agalar C.
        • Usubutun S.
        • Tutuncu E.
        • Turkylmaz R.
        Comparison of two regimens for ciprofloxacin treatment of enteric infections.
        Eur J Clin Microbiol Infect Dis. 1997; 16: 803-806
        • Tocalli L.
        • Nardi G.
        • Mammino A.
        • Salvaggio A.
        • Salvaggio L.
        Salmonellosis diagnosed by the laboratory of the “L. Sacco” Hospital of Milan (Italy) in patients with HIV disease.
        Eur J Epidemiol. 1991; 7: 690-695
        • Vugia D.J.
        • Kiehlbauch J.A.
        • Yeboue K.
        • et al.
        Pathogens and predictors of fatal septicemia associated with human immunodeficiency virus infection in Ivory Coast, West Africa.
        J Infect Dis. 1993; 168: 564-570
        • Ruiz Contreras J.
        • Ramos J.T.
        • Hernandez Sampelayo T.
        • et al.
        Sepsis in children with human immunodeficiency virus infection. The Madrid Pediatric Infection Collaborative Study Group.
        Pediatr Infect Dis J. 1995; 14: 522-526
        • Angulo F.J.
        • Swerdlow D.L.
        Bacterial enteric infections in persons infected with human immunodeficiency virus.
        Clin Infect Dis. 1995; 21: S84-S93
        • Nathoo K.J.
        • Chigonde S.
        • Nhembe M.
        • Ali M.H.
        • Mason P.R.
        Community-acquired bacteremia in human immunodeficiency virus-infected children in Harare, Zimbabwe.
        Pediatr Infect Dis J. 1996; 15: 1092-1097
        • Grant A.D.
        • Djomand G.
        • Smets P.
        • et al.
        Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Côte d'Ivoire.
        AIDS. 1997; 11: 1357-1364
        • Kovacs A.
        • Leaf H.L.
        • Simberkoff M.S.
        Management of the HIVinfected patient. Bacterial infections.
        Med Clin North Am. 1997; 81: 319-343
        • Brettle R.E.
        Bacterial infections in HIV: the extent and nature of the problem.
        Int J STD AIDS. 1997; 8: 5-15
        • Manfredi R.
        • Nanetti A.
        • Ferri M.
        • et al.
        Clinical and microbiological features of non-typhoid salmonellosis in patients with HIV infection.
        Mediterranean J Infect Parasitic Dis. 1994; 9: 165-170
        • Medina F.
        • Fuentes M.
        • Jara L.J.
        • Barile L.
        • Miranda J.M.
        • Fraga A.
        Salmonella pyomyositis in patients with the human immunodeficiency virus.
        Br J Rheumatol. 1995; 34: 568-571
        • Fernandez Guerrero M.L.
        • Torres Perea R.
        • Gomez Rodrigo J.
        • Nuñez Garcia A.
        • Jusdado J.J.
        • Ramos Rincon J.M.
        Infectious endocarditis due to non-typhi Salmonella in patients infected with human immunodeficiency virus: report of two cases and review.
        Clin Infect Dis. 1996; 22: 853-855
        • Fernandez Guerrero M.L.
        • Ramos J.M.
        • Nuñez A.
        • Cuenca M.
        • De Gorgolas M.
        Focal infections due to non-typhi Salmonella in patients with AIDS: report of 10 cases and review.
        Clin Infect Dis. 1997; 25: 690-697
        • Sperber S.J.
        • Feibusch E.
        • Damiani A.
        • et al.
        In vitro activities of nucleoside analog antiviral agents against Salmonellae.
        Antimicrob Agents Chemother. 1993; 37: 106-110
        • Sanchez-Carrillo C.
        • Menasalvas A.
        • Cotarelo M.
        • Diaz M.D.
        • Cercenado E.
        • Bouza E.
        In vitro activity of antiviral agents used in AIDS against Salmonella typhi and non-typhoid salmonella.
        J Antimicrob Chemother. 1996; 38: 153-154
        • Tumbarello M.
        • Tacconelli E.
        • Cauda R.
        • Ortona L.
        Role of trimethoprim-sulphamethoxazole in preventing HIV-associated bacteraemia.
        AIDS. 1997; 11: 1070-1071
        • Gilks C.F.
        • Brindle R.J.
        • Otieno L.S.
        • et al.
        Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya.
        Lancet. 1990; 336: 545-549
        • Houston S.
        Salmonella typhi bacteremia and HIV infection with common iliac artery occlusion.
        Cent Afr J Med. 1994; 40: 48-52
        • Khan M.
        • Coovadia Y.
        • Sturm A.W.
        Typhoid fever and asymptomatic human immunodeficiency virus infection. A report of 10 cases.
        J Clin Gastroenterol. 1997; 25: 507-512
        • Gotuzzo E.
        • Frisancho O.
        • Liendo G.
        • et al.
        Association between the acquired immunodeficiency syndrome and infection with Salmonella typhi or Salmonella paratyphi in an area endemic for typhoid fever.
        Arch Intern Med. 1991; 151: 381-382
        • Jarrett D.R.
        • Zeegen R.
        Recurrent typhoid in a HTLV-III antibody positive man.
        Gut. 1986; 27: 587-588
        • Sharma A.M.
        • Sharma O.P.
        Pulmonary manifestations of typhoid fever: two case reports and review of the literature.
        Chest. 1992; 101: 1144-1146
        • Drugas D.
        • Duarte B.
        • Robin A.
        • Barrett J.
        Salmonella typhi splenic abscess in an intravenous drug abuser following splenorrhaphy: case report.
        J Trauma. 1992; 33: 143-144
        • Hedriana H.L.
        • Mitchell J.L.
        • Williams S.B.
        Salmonella typhi chorioamnionitis in a human immunodeficiency virus infected pregnant woman. A case report.
        J Reprod Med. 1995; 40: 157-159
        • Manfredi R.
        • Mastroianni A.
        • Coronado O.V.
        • Chiodo E.
        Imported tropical diseases in subjects with HIV infection.
        Panminerva Med. 1998; 40: 72-74

      Article info

      Identification

      DOI: https://doi.org/10.1016/S1201-9712(99)90018-8

      Copyright

      © 1999 Published by Elsevier Inc.

      User license

      Elsevier user license |
      How you can reuse Information Icon
      Elsevier user license

      Permitted

      For non-commercial purposes:

      • Read, print & download
      • Text & data mine
      • Translate the article

      Not Permitted

      • Reuse portions or extracts from the article in other works
      • Redistribute or republish the final article
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX